- Home
- GLRE vs RXST Comparison
GLRE vs RXST Comparison
Compare GLRE & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLRE
- RXST
- Stock Information
- Founded
- GLRE 2004
- RXST 1997
- Country
- GLRE Cayman Islands
- RXST United States
- Employees
- GLRE N/A
- RXST N/A
- Industry
- GLRE Property-Casualty Insurers
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GLRE Finance
- RXST Health Care
- Exchange
- GLRE Nasdaq
- RXST Nasdaq
- Market Cap
- GLRE 439.8M
- RXST 385.0M
- IPO Year
- GLRE 2007
- RXST 2021
- Fundamental
- Price
- GLRE $12.64
- RXST $8.31
- Analyst Decision
- GLRE
- RXST Hold
- Analyst Count
- GLRE 0
- RXST 11
- Target Price
- GLRE N/A
- RXST $11.80
- AVG Volume (30 Days)
- GLRE 187.6K
- RXST 784.0K
- Earning Date
- GLRE 11-03-2025
- RXST 11-06-2025
- Dividend Yield
- GLRE N/A
- RXST N/A
- EPS Growth
- GLRE N/A
- RXST N/A
- EPS
- GLRE 1.10
- RXST N/A
- Revenue
- GLRE $695,657,000.00
- RXST $147,059,000.00
- Revenue This Year
- GLRE N/A
- RXST N/A
- Revenue Next Year
- GLRE N/A
- RXST $6.71
- P/E Ratio
- GLRE $11.48
- RXST N/A
- Revenue Growth
- GLRE 0.97
- RXST 27.68
- 52 Week Low
- GLRE $12.14
- RXST $6.32
- 52 Week High
- GLRE $15.82
- RXST $55.57
- Technical
- Relative Strength Index (RSI)
- GLRE 44.24
- RXST 40.55
- Support Level
- GLRE $12.50
- RXST $8.26
- Resistance Level
- GLRE $12.68
- RXST $9.38
- Average True Range (ATR)
- GLRE 0.21
- RXST 0.42
- MACD
- GLRE -0.01
- RXST -0.12
- Stochastic Oscillator
- GLRE 31.72
- RXST 4.86
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.